Abstract:Hotspot mutations in the NRAS gene are causative genetic events associated with the development of melanoma. Currently, there are no FDA-approved drugs directly targeting NRAS mutations. Previously, we showed that p38 acts as a tumor suppressor in vitro and in vivo with respect to NRAS-mutant melanoma. We observed that because of p38 activation through treatment with the protein synthesis inhibitor, anisomycin leads to a transient upregulation of several targets of the cAMP pathway, representing a stressed cancer cell state that is often observed by therapeutic doses of MAPK inhibitors in melanoma patients. Meanwhile, genetically induced p38 or its stable transduction leads to a distinct cellular transcriptional state. Contrary to previous work showing an association of invasiveness with high p38 levels in BRAF-mutated melanoma, there was no correlation of p38 expression with NRAS-mutant melanoma invasion, highlighting the difference in BRAF and NRAS-driven melanomas. Although the role of p38 has been reported to be that of both tumor suppressor and oncogene, we show here that p38 specifically plays the role of a tumor suppressor in NRAS-mutant melanoma. Both the transient and stable activation of p38 elicits phosphorylation of mTOR, reported to be a master switch in regulating autophagy. Indeed, we observed a correlation between elevated levels of phosphorylated mTOR and a reduction in LC3 conversion (LCII/LCI), indicative of suppressed autophagy. Furthermore, a reduction in actin intensity in p38–high cells strongly suggests a role of mTOR in regulating actin and a remodeling in the NRAS-mutant melanoma cells. Therefore, p38 plays a tumor suppressive role in NRAS-mutant melanomas at least partially through the mechanism of mTOR upregulation, suppressed autophagy, and reduced actin polymerization. One or more combinations of MEK inhibitors with either anisomycin, rapamycin, chloroquine/bafilomycin, and cytochalasin modulate p38 activation, mTOR phosphorylation, autophagy, and actin polymerization, respectively, and they may provide an alternate route to targeting NRAS-mutant melanoma.

p38 MAPKs regulate the expression of genes in the dopamine synthesis pathway through phosphorylation of NR4A nuclear receptors

DPP-mediated TGFβ Signaling Regulates Juvenile Hormone Biosynthesis by Activating the Expression of Juvenile Hormone Acid Methyltransferase

Regulation of Drosophila p38 activation by specific MAP2 kinase and MAP3 kinase in response to different stimuli.

[P38 MAPK Signaling Pathway Regulates Nuclear Factor-Κb and Inducible Nitric Oxide Synthase Expressions in the Substantia Nigra in a Mouse Model of Parkinson's Disease].

Evolutionarily conserved transcription factors drive the oxidative stress response in Drosophila

Multiple activation mechanisms of p38alpha mitogen-activated protein kinase.

The P38 Pathway Regulates Oxidative Stress Tolerance by Phosphorylation of Mitochondrial Protein IscU

Disruption of Transient Receptor Potential Melastatin 2 Attenuate Lipopolysaccharide-Induced Heme Oxygenase-1 Expression in Mouse Macrophages Through P38 Mitogen-Activated Protein Kinase (P5202)

Mae Inhibits Pointed-P2 Transcriptional Activity by Blocking Its Mapk Docking Site

Molecular Identification and Functional Characterization of a Drosophila Dual-Specificity Phosphatase DMKP-4 Which is Involved in PGN-induced Activation of the JNK Pathway.

The kinase p38α functions in dendritic cells to regulate Th2-cell differentiation and allergic inflammation

Feedback Control of MKP-1 Expression by P38

Participation of the P38 Pathway in Drosophila Host Defense Against Pathogenic Bacteria and Fungi

P38α Signaling Programs Dendritic Cells to Drive TH17 Cell Differentiation and Function (48.14)

Molecular And Potential Regulatory Mechanisms Of Melanin Synthesis In Harmonia Axyridis

An in Vitro Study of NF-κB Factors Cooperatively in Regulation of Drosophila Melanogaster Antimicrobial Peptide Genes

Pro-Inflammatory Cytokines and Environmental-Stress Cause P38 Mitogen-Activated Protein-Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine

P38 Mediates Tumor Suppression through Reduced Autophagy and Actin Cytoskeleton Changes in NRAS-Mutant Melanoma

Toll-like Receptor 9 Regulates Melanogenesis Through NF-κB Activation

Syntenin regulates melanogenesis via the p38 MAPK pathway

Signaling by P38 MAPK Stimulates Nuclear Localization of the Microprocessor Component P68 for Processing of Selected Primary MicroRNAs